SWM
TXG icon

Sugarloaf Wealth Management’s 10x Genomics TXG Stock Holding History

Sugarloaf Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$1K – 864
2022
Q3 		$1K Hold
7
– – ﹤0.01% 803
2022
Q2 		$0 Hold
7
– – ﹤0.01% 831
2022
Q1 		$1K Hold
7
– – ﹤0.01% 701
2021
Q4 		$1K Hold
7
– – ﹤0.01% 728
2021
Q3 		$1K Hold
7
– – ﹤0.01% 743
2021
Q2 		$1K Sell
7
-100
-93% -$18.1K ﹤0.01% 734
2021
Q1 		$19 Buy
107
+100
+1,429% +$17.3K 0.01% 420
2020
Q4 		$1K Buy
+7
New +$1.02K ﹤0.01% 695

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sugarloaf Wealth Management's TXG Position: Q4 2022 in Review

Sugarloaf Wealth Management sold out of 10x Genomics (TXG) in Q4 2022, closing a stake of 7 shares — an estimated $1K sold.

Sugarloaf Wealth Management first reported a position in TXG in Q4 2020 and held it in 8 quarters. The position peaked at $1K in Q3 2022. 268 funds tracked by Wall St. Rank hold TXG as of Q4 2022.

  • Sugarloaf Wealth Management reported no remaining 10x Genomics position as of Q4 2022 after selling out during the quarter.
  • Sugarloaf Wealth Management sold 7 10x Genomics shares in Q4 2022, an estimated $1K.
  • Sugarloaf Wealth Management first reported a position in 10x Genomics in Q4 2020 and held it in 8 quarters.
  • Sugarloaf Wealth Management's 10x Genomics position peaked at $1K in Q3 2022.
  • 268 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2022.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.